Essential Information to Make Documenting Pharmaceutical Advisory Boards Easier

Pharmaceutical Advisory Boards play a vital role. They bring experts from around the world together. Virtual meetings are a popular way of achieving this. They allow ground-breaking data and opinions to be shared and recorded. This can often be at short notice. Meetings connect experts from any part of the globe, at any time. Audio transcription of pharmaceutical advisory board meetings is considered essential.

Researchers, medics, funders and academics can be members of pharmaceutical advisory boards. Board meetings play an important role in decision-making. They formulate clinical trial protocols, treatment plan research and aid brainstorming and learning. But they can be difficult to transcribe. Alphabet are experts in audio transcription for this complex and specialised field. We understand that insights must meet international standards and offer value.

In this guide, we explain the basics of pharmaceutical advisory boards. We also outline best practice for crystal clear, accurate and valuable audio transcription.

What Are Pharmaceutical Advisory Boards?

The pharmaceutical industry has had advisory boards for decades. They further research and commercial goals. Meetings aid the complex and highly-regulated world of pharmaceutical research. They achieve this by bringing experts together. Pharmaceutical advisory boards allow specialists to share opinions, set budgets and discuss data. They may evaluate regulatory requirements for a clinical trial or set protocols for new research. Enter audio transcription.

New technology is driving greater use of pharmaceutical advisory boards. Experts no longer have to travel halfway around the world to share data. Now they connect via webcam or a conference call – at the click of a button. These meetings take place at very short notice, giving organisers little time to plan how the process will play out. Audio transcription of advisory meetings is not for a novice. Transcribers need an understanding of research, as well as medical and pharmaceutical terminology. They also need patience and high levels of concentration.

Those who fund clinical trials expect more for their money. That is why businesses and charities are playing a bigger role on pharmaceutical advisory boards. The need is increasing for quality clinical data and clear indicators of health outcomes. Such information helps them decide the worth of new drugs in a competitive marketplace. In some countries, governments fund clinical trials. This is where value for money is an added pressure on pharmaceutical companies.

Bringing new drugs or treatment methods to market is a time-consuming and expensive affair. It is also bound by regulations. Compliance is key to success. Regulations now include rules concerning payments to certain experts. New codes of conduct include medics. Stringent reporting rules have affected the way the pharma industry conducts pharmaceutical advisory board meetings. However, they remain highly complex.

Some experts claim the average advisory board meeting will take four months to plan. But many are held within weeks of their inception. Best practices currently cover things like internal stakeholders, the importance of audio transcription and distribution of insights. They also offer guidance on measuring the success of meetings. Advisory board members are usually selected by those leading pharmaceutical studies. Experts in their field, they are often appointed for a set timescale.

The Value of Audio Transcription and Pharmaceutical Advisory Boards

The point of pharmaceutical advisory boards is to share and evaluate information. That is why it is important that discussions are documented thoroughly. Audio transcription is an absolute ‘must’. Transcription accurately converts sound files to text documents that can form the basis of clinical trial outcomes. They provide a written record of what was said at a meeting. This furthers the goals of the pharma industry.

Considered a critical element of research, product development and funding, pharmaceutical advisory boards perform difficult tasks. This can include evaluating data from multiple sources and in more than one format. Charts and even rough notes can complicate an already complex mix. It makes sense to record everything in one text document.

All UK healthcare professionals appointed to pharmaceutical advisory boards must comply with rules. They are set out in the Association of the British Pharmaceutical Industry (ABPI) Code of Practice. Audio transcription experts understand this. They take care to ensure sound files are faithfully recorded to avoid misrepresenting the conduct of those taking part in meetings.

Because written documentation is versatile, it is valuable. Data collected from pharmaceutical advisory boards will go on to be used in reports, for educational purposes and in medical journals. It can also form the basis of clinical practices and drive further research. Audio transcription makes sense of what, to an outsider, can sound chaotic.

Why Audio Transcription of Pharmaceutical Advisory Boards is Difficult

Aside from the terminology and highly complex nature of many board discussions, you have got multiple speakers. Not only that, they come from all over the world. You have people sharing opinions – occasionally at the same time – with strong, often hard-to-decipher accents. They may use a word or phrase in their native language that will require research to fully understand. Throw in visual data that may not be clearly explained orally as well as open questions and you get the picture.

While great effort is being put into pharmaceutical advisory boards and their management, how they end up being conducted can complicate an already overwhelming situation. Pharmaceutical companies are working hard to further increase the value of advisory board meetings. They are utilising new technologies, including those offered by audio transcription experts such as ourselves. Coupled with a desire to improve standards of documentation, they are working on best practice for the management of meetings as they happen.

Other areas are being developed which will also aid audio transcription. They include how meetings are co-ordinated and by whom. The aim here is to increase the output of written documentation that will add value to research. Expert audio transcription companies offer project management services that take care of documentation timescales and much more.

Need a pharmaceutical advisory board audio transcription expert? Talk to Alphabet today.

Making Pharmaceutical Advisory Boards Easier to Document

The pharma industry is the first to admit that advisory board meetings need better co-ordination to improve output. It understands that expert contributors are busy people. However, in order to evaluate their contributions and include them in important advancements, they must be clear. So, how can we make meetings easier for these busy experts? And how can reports better reflect the value of discussions?

Lots of enterprises with an interest in pharmaceutical medical boards have come up with suggestions. Many have pointed to regular anomalies that weaken the value of a report. For example, comments by board members such as: “As you will see in this critical data chart.” The pharma industry has realised that ‘critical’ data has to have a name to be of lasting value. That is why Alphabet encourage board members to give their charts and data a name. Mentioned in audio transcription in the right place and in the right context, it will make chart data easy to add.

Meeting concepts are now emerging to bring together objectives and viewpoints. We recommend pharmaceutical board meetings are planned with a clear objective in mind. They should include elements where direct questions are posed. Board members should be encouraged to speak in turn and clearly. Each should state their name and expert role at the start of the meeting.

Agendas for pharmaceutical board meetings should be circulated in advance. This will help those taking part to prepare and understand where their expert input is likely to offer value. Prioritise goals. What, for example, will be of most benefit and what is the least critical? By understanding what you want to get out of an advisory board meeting, you can decide who really needs to be on the invitation list.

Make sure the person chairing the meeting fully understands its aims. Discuss the meeting plan. If very complex data is going to be presented, the person doing the presenting may want to double-check they have got everything they need. A practice run can iron out issues with technology, including slides of charts or information contained in video format.

Timing is crucial. Pharmaceutical advisory board meetings need to share information in a format that doesn’t lead to an audio transcription that could stretch from London to Perth. Sticking to the agenda will aid the audio transcription process. It will increase the value of insights shared at a meeting.

The Future of Pharmaceutical Advisory Boards

With greater attention to the planning of meetings, pharmaceutical advisory boards could play an even greater role in the advancement of medicine. Insights shared are likely to create ongoing dialogue that could drive new, pioneering research. Better co-ordination and a commitment to quality will make funding, clinical trials and brainstorming easier.

It is such a complex field. Adding an element of simplicity makes sense. The evolving relationship between pharmaceutical companies and medical and funding stakeholders is under constant scrutiny. The introduction of the Sunshine Act has altered how board meetings are approached around the globe. With greater emphasis on regulation in the field of pharmaceutical research, the value of board meetings must be clearly demonstrated. Transparency at every level of the pharma industry is now essential.

Pharmaceuticals have transformed the way they engage with experts. But there is a new challenge and opportunity on the horizon. That is patient access to drug trials. It is big news in the UK. That is thanks to the late former Cabinet Minister Dame Tessa Jowell. She campaigned for greater access to different treatments. Specifically, drugs still in the development stage. She argued that people with little time left have nothing to lose by switching from one new drug to another. Most would do so in the hope of finding one that extends their life.

Tessa lost her battle against an aggressive form of brain cancer. But not before she opened up a new world of opportunity. Her insights will benefit both patients and pharmaceutical companies. This is a brave new era for medicine. It is one that can win the support of funders through the renewed enthusiasm of patients. As Tessa herself said, “In the end, what gives a life meaning is not only how it is lived, but how it draws to a close.”

Before her death earlier this year, Tessa urged the Government to change NHS rules. She said cancer patients were willing to take the risks associated with developing pharma breakthroughs. She called on the Government to allow patients to try new drugs – without having to take on the battle of fighting red tape.

She gave a speech in the House of Lords just days before her death. It received cross-party support. After the event, Ministers said they would do everything they could to make it easier for cancer patients to try innovative therapies.

This presents new opportunities for pharmaceutical advisory boards. It gives them the scope to clinical trials in the broader context of patients.

Audio Transcription Experts for Pharmaceutical Advisory Board Meetings

Do you want accurate, error-free audio transcription of pharmaceutical medical board meetings? Talk to Alphabet. We’re experts in the field of complex, multi-speaker sound files. Companies and researchers trust us to deliver excellence and value. That is why some of the biggest names in the business are our clients. Alphabet has been an expert in audio transcription for more than 20 years. We understand the complexities of highly specialised fields.

We work with pharmaceutical companies around the globe. They trust us to understand their business because it is a part of ours. We take pride in offering transcription services that deliver quality documentation. High standards are needed to further pharmaceutical advancements.

Because we value accuracy, we undertake background research thoroughly. Our team do not phonetically guess medical and scientific terminology. We know the importance of our work in the field of pharmaceutical advisory boards. At the end of the day, this is work that benefits patients, research and economies.

Want further information about our audio pharmaceutical transcription services? You can contact us by telephoning +44 (0) 1707 260027.